Belgium· BE-AMP-SAM213473-00

Aseptiderm 0.5 %

A cetrimide product containing cetrimide, registered in Belgium by Laboratoires Belges Pharmacobel. The same ATC class is registered in 2 of our 19 countries.

ATC D08AJ04

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAseptiderm 0.5 %ATCD08AJ04REGISTER NO.BE-AMP-SAM213473-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Cetrimide is registered in 2 of 19 countries.

Countries holding a registration under ATC D08AJ04 (cetrimide), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 1 of them publish a price we can compare per daily dose

Cetrimide · ATC D08AJ04

2 / 19 countries

  • Belgiumprice
  • Ireland
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Cetrimide
Manufacturer
Laboratoires Belges Pharmacobel
Country
Belgium (BE)
ATC code
D08AJ04
ATC class
Cetrimide
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cetrimide in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cetrimide products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • France · Cetavlon
  • United Kingdom (Northern Ireland) · Antiseptic First Aid Sainsburys, Antiseptic Wound Wash
  • Portugal · Cetavlex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1d5c0661-beb7-4a04-a8a2-0d6f574d0111
GET /v1/drugs/1d5c0661-beb7-4a04-a8a2-0d6f574d0111?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Cutaneous solution",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Aseptiderm 0.5 %",
  "name_fr": "Aseptiderm 0.5 %",
  "name_nl": "Aseptiderm 0.5 %",
  "amp_code": "SAM213473-00",
  "strengths": [
    "500.0000",
    "500.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Cetrimide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Cetrimide",
  "authorisation_numbers": [
    "BE213473"
  ]
}

See everything about cetrimide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.